Quick Answer
BetterLife Pharma Inc. reported Earnings Per Share Diluted of $0.11 (loss) per share for the year ending 2016.
- BetterLife Pharma Inc. showed a decrease of -10.0% in Earnings Per Share Diluted from 2015 to 2016.
- This data is from BetterLife Pharma Inc.'s annual report (Form 10-K), filed with the SEC on April 29, 2016.
- XBRL data for this metric is available from 2014 to 2016 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2014: $0.01 per share | Q3 2014: $0.00 per share | Q4 2014: $0.00 per share | Q2 2015: $0.02 (loss) per share | Q3 2015: $0.04 (loss) per share | Q4 2015: $0.00 per share | Q2 2016: $0.04 (loss) per share | Q4 2016: $0.01 (loss) per share | Q4 2017: $0.01 per share | Q2 2018: $0.03 (loss) per share | Q4 2018: $0.04 (loss) per share | Q2 2019: $0.02 (loss) per share.
- Over the full 3 years of available data (2014 to 2016), BetterLife Pharma Inc.'s Earnings Per Share Diluted has grown by 45.0%.
- Historical annual values: Fiscal year 2016: $0.11 (loss) per share | Fiscal year 2015: $0.10 (loss) per share | Fiscal year 2014: $0.20 (loss) per share.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: